Unknown

Dataset Information

0

Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer.


ABSTRACT: Mutations within the epidermal growth factor receptor (EGFR/erbB1/Her1) are often associated with tumorigenesis. In particular, a number of EGFR mutants that demonstrate ligand-independent signaling are common in non-small cell lung cancer (NSCLC), including kinase domain mutations L858R (also called L834R) and exon 19 deletions (e.g., ?L747-P753insS), which collectively make up nearly 90% of mutations in NSCLC. The molecular mechanisms by which these mutations confer constitutive activity remain unresolved. Using multiple subdiffraction-limit imaging modalities, we reveal the altered receptor structure and interaction kinetics of NSCLC-associated EGFR mutants. We applied two-color single quantum dot tracking to quantify receptor dimerization kinetics on living cells and show that, in contrast to wild-type EGFR, mutants are capable of forming stable, ligand-independent dimers. Two-color superresolution localization microscopy confirmed ligand-independent aggregation of EGFR mutants. Live-cell Förster resonance energy transfer measurements revealed that the L858R kinase mutation alters ectodomain structure such that unliganded mutant EGFR adopts an extended, dimerization-competent conformation. Finally, mutation of the putative dimerization arm confirmed a critical role for ectodomain engagement in ligand-independent signaling. These data support a model in which dysregulated activity of NSCLC-associated kinase mutants is driven by coordinated interactions involving both the kinase and extracellular domains that lead to enhanced dimerization.

SUBMITTER: Valley CC 

PROVIDER: S-EPMC4710239 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer.

Valley Christopher C CC   Arndt-Jovin Donna J DJ   Karedla Narain N   Steinkamp Mara P MP   Chizhik Alexey I AI   Hlavacek William S WS   Wilson Bridget S BS   Lidke Keith A KA   Lidke Diane S DS  

Molecular biology of the cell 20150902 22


Mutations within the epidermal growth factor receptor (EGFR/erbB1/Her1) are often associated with tumorigenesis. In particular, a number of EGFR mutants that demonstrate ligand-independent signaling are common in non-small cell lung cancer (NSCLC), including kinase domain mutations L858R (also called L834R) and exon 19 deletions (e.g., ΔL747-P753insS), which collectively make up nearly 90% of mutations in NSCLC. The molecular mechanisms by which these mutations confer constitutive activity remai  ...[more]

Similar Datasets

| S-EPMC4187709 | biostudies-literature
| S-EPMC4254573 | biostudies-literature
| S-EPMC4496187 | biostudies-literature
| S-EPMC3039292 | biostudies-literature
| S-EPMC6717865 | biostudies-literature
| S-EPMC5037433 | biostudies-literature
| S-EPMC6192927 | biostudies-literature
| S-EPMC5814225 | biostudies-literature
| S-EPMC6356910 | biostudies-literature
| S-EPMC10797396 | biostudies-literature